Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 320

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 320
---
 without the joinder of the other, as his or her true and lawful attorneys in fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post effective amendments) to this registration statement and any registration statement (including any amendment thereto) for this offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the SEC, granting unto said attorneys in fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or would do in person, hereby ratifying and confirming all that said attorneys in fact and agents or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act, this registration statement has been signed below by the following persons in the capacities and the dates indicated.

| Signature               |     | Title                                             |     |   Date |
| Jeffrey Sprau           |     | Chief Executive Officer and Director              
 (Principal Executive Officer)                     |     | , 2025 |
| Stephen Butz            |     | Executive Vice President, Chief Financial Officer 
 (Principal Financial Officer)                     |     | , 2025 |
| Philippe Le Bris        |     | Chief Accounting Officer                          
 (Principal Accounting Officer)                    |     | , 2025 |
| Bilal Khan              |     | Director                                          |     | , 2025 |
| Robert Mitchell Nimocks |     | Director                                          |     | , 2025 |

II-5